366 related articles for article (PubMed ID: 19041023)
1. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
Pepe P; Fraggetta F; Galia A; Grasso G; Piccolo S; Aragona F
Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
[TBL] [Abstract][Full Text] [Related]
2. Prediction by quantitative histology of pathological stage in prostate cancer.
Pepe P; Galia A; Fraggetta F; Grasso G; Allegro R; Aragona F
Eur J Surg Oncol; 2005 Apr; 31(3):309-13. PubMed ID: 15780569
[TBL] [Abstract][Full Text] [Related]
3. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
Pepe P; Aragona F
Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
[TBL] [Abstract][Full Text] [Related]
4. Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
Isbarn H; Karakiewicz PI; Vogel S; Jeldres C; Lughezzani G; Briganti A; Montorsi F; Perrotte P; Ahyai SA; Budäus L; Eichelberg C; Heuer R; Köllermann J; Sauter G; Schlomm T; Steuber T; Haese A; Zacharias M; Fisch M; Heinzer H; Huland H; Chun FK; Graefen M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):784-7. PubMed ID: 19864083
[TBL] [Abstract][Full Text] [Related]
5. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
6. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW
J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262
[TBL] [Abstract][Full Text] [Related]
7. Is a single focus of low-grade prostate cancer diagnosed on saturation biopsy predictive of clinically insignificant cancer?
Pepe P; Fraggetta F; Galia A; Candiano G; Grasso G; Aragona F
Urol Int; 2010; 84(4):440-4. PubMed ID: 20234121
[TBL] [Abstract][Full Text] [Related]
8. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
Abdollah F; Scattoni V; Raber M; Roscigno M; Briganti A; Suardi N; Gallina A; Capitanio U; Freschi M; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Aug; 108(3):366-71. PubMed ID: 21087451
[TBL] [Abstract][Full Text] [Related]
9. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
Ochiai A; Troncoso P; Chen ME; Lloreta J; Babaian RJ
J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
[TBL] [Abstract][Full Text] [Related]
10. Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt.
Müntener M; Kunz U; Eichler K; Puhan M; Schmid DM; Sulser T; Strebel RT
Urol Int; 2010; 84(2):141-6. PubMed ID: 20215816
[TBL] [Abstract][Full Text] [Related]
11. Prediction of prostate carcinoma stage by quantitative biopsy pathology.
Veltri RW; Miller MC; Partin AW; Poole EC; O'Dowd GJ
Cancer; 2001 Jun; 91(12):2322-8. PubMed ID: 11413521
[TBL] [Abstract][Full Text] [Related]
12. Is PCA3 score useful in preoperative staging of a single microfocus of prostate cancer diagnosed at saturation biopsy?
Pepe P; Fraggetta F; Galia A; Aragona F
Urol Int; 2012; 89(2):143-7. PubMed ID: 22868485
[TBL] [Abstract][Full Text] [Related]
13. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
Falzarano SM; Zhou M; Hernandez AV; Moussa AS; Jones JS; Magi-Galluzzi C
Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973
[TBL] [Abstract][Full Text] [Related]
14. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
Obek C; Louis P; Civantos F; Soloway MS
J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
[TBL] [Abstract][Full Text] [Related]
15. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
16. Does Ki-67 staining improve quantitative histology in preoperative prostate cancer staging?
Pepe P; Fraggetta F; Candiano G; Aragona F
Arch Ital Urol Androl; 2012 Mar; 84(1):32-5. PubMed ID: 22649958
[TBL] [Abstract][Full Text] [Related]
17. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
Scales CD; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ;
J Urol; 2007 Oct; 178(4 Pt 1):1249-52. PubMed ID: 17698131
[TBL] [Abstract][Full Text] [Related]
18. Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.
Haese A; Chaudhari M; Miller MC; Epstein JI; Huland H; Palisaar J; Graefen M; Hammerer P; Poole EC; O'Dowd GJ; Partin AW; Veltri RW
Cancer; 2003 Feb; 97(4):969-78. PubMed ID: 12569595
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
[TBL] [Abstract][Full Text] [Related]
20. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
Anast JW; Andriole GL; Bismar TA; Yan Y; Humphrey PA
Urology; 2004 Sep; 64(3):544-50. PubMed ID: 15351590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
